http://money.cnn.com/news/newsfeeds/articles/prnewswire/NY80429.htm
NEW YORK, Sept. 25, 2012 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Peregrine Pharmaceuticals, Inc. ("Peregrine" or the "Company") (NasdaqCM: PPHM -News), concerning potential violations of federal securities laws.
There will likely be other Law firms who smell blood too.